NCT02004509 Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial Status RECRUITING Phase PHASE4
NCT01999829 Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo Status COMPLETED Phase PHASE3
NCT01996943 The HOLIDAY (HOw ALcohol InDuces Atrial TachYarrhythmias) Study Status COMPLETED Phase NA
NCT01994265 Cognitive Impairment Related to Atrial Fibrillation Prevention Trial Status COMPLETED Phase PHASE4
NCT01994252 Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation Status COMPLETED Phase NA
NCT01994070 Chemical vs Electrical Cardioversion for Emergency Department Patients With Acute Atrial Fibrillation Status COMPLETED Phase PHASE3
NCT01991951 Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation Status UNKNOWN Phase NA
NCT01991119 Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation Status COMPLETED Phase NA
NCT01990911 Renal Sympathetic Denervation Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study Status COMPLETED Phase NA
NCT01988974 Feasibility Testing of the Alert for Atrial Fibrillation Program Status COMPLETED Phase NA
NCT01985425 Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study Status COMPLETED Phase PHASE3
NCT01983813 Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care Status COMPLETED Phase NA
NCT01976507 Use of Dabigatran Etexilate to Prevent Stroke and Thromboembolism Status COMPLETED Phase PHASE4
NCT01972295 Registry on WATCHMAN Outcomes in Real-Life Utilization WASP Registry Status COMPLETED Phase N/A
NCT01962545 Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study Status COMPLETED Phase PHASE4
NCT01962051 AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational Status WITHDRAWN Phase N/A
NCT01959997 Comparison of Redo PVI With vs. Without Renal Denervation for Recurrent AF After Initial PVI Status UNKNOWN Phase PHASE2
NCT01952743 Renal Denervation Therapy in Hypertensive Patients Undergoing A-Fib Ablation Status TERMINATED Phase NA